Heterogeneity in Parent Preferences for Peanut Desensitization Therapy.

Journal Article (Journal Article)

BACKGROUND: Recently developed peanut desensitization treatment reduces the incidence of allergic reactions, the anxiety associated with the risk of accidental exposure, and the burden of precautionary behavior. Eliciting parent preferences for tradeoffs involving treatment effectiveness, tolerability, costs, and convenience quantifies the burden of juvenile peanut allergy and the perceived value of peanut desensitization therapies. OBJECTIVE: To understand heterogeneity in parents' treatment preferences and the role of personal characteristics in explaining differences. METHODS: An Internet-based, discrete-choice experiment survey was administered to a national sample of 500 parents of children aged 4 to 17 years with peanut allergy to quantify parents' preferences for peanut desensitization therapies for their children. Latent-class, mixed-logit analysis estimated relative importance coefficients for groups of participants with distinctly different preferences. RESULTS: Parents' choice patterns fell into 1 of 4 preference subgroups: (1) Cost-sensitive, (2) Protreatment (but Side-Effect-Averse), (3) Trader, and (4) Inconsistent. Mode of administration had little relative importance across all subgroups. Characteristics associated with belonging to a given preference subgroup included parent age, child age, income, parent perception of child risk and ability to manage allergic reactions, past allergic reactions, and changes in precautionary behaviors posttreatment. CONCLUSIONS: We found distinct differences in parent preferences for tradeoffs involving effectiveness, tolerability, and costs of peanut desensitization treatments. Parents' treatment preferences help quantify the burden of juvenile peanut allergy and the perceived value of new therapies. Such information can inform patient-centric clinical and regulatory decision making.

Full Text

Duke Authors

Cited Authors

  • Hung, A; Gonzalez, JM; Yang, J-C; Hass, S; Kim, E; Johnson, FR

Published Date

  • September 2021

Published In

Volume / Issue

  • 9 / 9

Start / End Page

  • 3459 - 3465

PubMed ID

  • 33965597

Electronic International Standard Serial Number (EISSN)

  • 2213-2201

Digital Object Identifier (DOI)

  • 10.1016/j.jaip.2021.04.058


  • eng

Conference Location

  • United States